• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Immunomodulatory activity of (oral administration of gold as electuary) in infants - A randomized controlled clinical trial.(口服金制剂糖剂)对婴儿的免疫调节活性——一项随机对照临床试验
Ayu. 2019 Oct-Dec;40(4):230-236. doi: 10.4103/ayu.AYU_33_19. Epub 2021 Jan 14.
2
Swarna Bindu Prashana-an Ancient Approach to Improve the Infant's Immunity.苏瓦尔纳宾度普拉沙那——一种提高婴儿免疫力的古老方法。
Biol Trace Elem Res. 2021 Jun;199(6):2145-2148. doi: 10.1007/s12011-020-02353-y. Epub 2020 Aug 27.
3
- faith in the embrace of research.对研究的信赖。
J Complement Integr Med. 2021 Nov 11;19(2):161-172. doi: 10.1515/jcim-2021-0394. eCollection 2022 Jun 1.
4
Characterization of Swarna Bhasma and Swarnaprash and Determination of Antimicrobial Properties Against Gut-Pathobiont and Symbiont.金色煅灰和金色糖浆的特性表征以及对肠道致病共生菌和共生菌的抗菌特性测定
Biol Trace Elem Res. 2025 May;203(5):2924-2932. doi: 10.1007/s12011-024-04353-8. Epub 2024 Sep 6.
5
Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug.阿育吠陀药物斯瓦纳·巴斯马(金巴斯马)的血液相容性研究。
Int J Ayurveda Res. 2011 Jan;2(1):14-22. doi: 10.4103/0974-7788.83183.
6
Evaluation of the effect of conventionally prepared swarna makshika bhasma on different bio-chemical parameters in experimental animals.传统制备的金色硫黄散对实验动物不同生化参数影响的评估。
J Ayurveda Integr Med. 2011 Oct;2(4):187-91. doi: 10.4103/0975-9476.90773.
7
Standard manufacturing process of Makaradhwaja prepared by Swarna Patra - Varkha and Bhasma.
Ayu. 2011 Jan;32(1):109-15. doi: 10.4103/0974-8520.85741.
8
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
9
X-Ray Diffraction of different samples of Swarna Makshika Bhasma.金色硫砷汞矿煅灰不同样品的X射线衍射分析
Ayu. 2015 Apr-Jun;36(2):225-9. doi: 10.4103/0974-8520.175547.
10
Swarna Bhasma in cancer: A prospective clinical study.癌症中的斯瓦纳·巴斯马:一项前瞻性临床研究。
Ayu. 2012 Jul;33(3):365-7. doi: 10.4103/0974-8520.108823.

引用本文的文献

1
Nature and mechanism of immune boosting by Ayurvedic medicine: A systematic review of randomized controlled trials.阿育吠陀医学增强免疫力的本质与机制:随机对照试验的系统评价
World J Methodol. 2022 May 20;12(3):132-147. doi: 10.5662/wjm.v12.i3.132.

本文引用的文献

1
Blood compatibility studies of Swarna bhasma (gold bhasma), an Ayurvedic drug.阿育吠陀药物斯瓦纳·巴斯马(金巴斯马)的血液相容性研究。
Int J Ayurveda Res. 2011 Jan;2(1):14-22. doi: 10.4103/0974-7788.83183.
2
Explaining odds ratios.解释比值比
J Can Acad Child Adolesc Psychiatry. 2010 Aug;19(3):227-9.
3
In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size.金纳米颗粒经大鼠皮肤和大鼠肠道的体外渗透:粒径的影响。
Colloids Surf B Biointerfaces. 2008 Aug 1;65(1):1-10. doi: 10.1016/j.colsurfb.2008.02.013. Epub 2008 Feb 26.
4
The maturing immune system: implications for development and testing HIV-1 vaccines for children and adolescents.成熟的免疫系统:对儿童和青少年HIV-1疫苗研发与测试的启示
AIDS. 2006 Feb 28;20(4):483-94. doi: 10.1097/01.aids.0000210602.40267.60.
5
Proportions, odds, and risk.比例、比值和风险。
Radiology. 2004 Jan;230(1):12-9. doi: 10.1148/radiol.2301031028.
6
Evaluation of chemical constituents and free-radical scavenging activity of Swarnabhasma (gold ash), an ayurvedic drug.对一种阿育吠陀药物——金色灰(Swarnabhasma)的化学成分及自由基清除活性的评估。
J Ethnopharmacol. 2002 May;80(2-3):147-53. doi: 10.1016/s0378-8741(02)00008-9.
7
Augmentation of non-specific immunity in mice by gold preparations used in traditional systems of medicine.传统医学体系中使用的金制剂对小鼠非特异性免疫的增强作用。
Indian J Med Res. 2001 May;113:192-6.
8
Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles.
J Pharm Sci. 2001 Dec;90(12):1927-36. doi: 10.1002/jps.1143.
9
Immunomodulatory activity of a Unani gold preparation used in Indian system of medicine.
Immunopharmacol Immunotoxicol. 1999 Feb;21(1):151-61. doi: 10.3109/08923979909016400.
10
The number needed to treat: a clinically useful measure of treatment effect.需治疗人数:一种临床实用的治疗效果衡量指标。
BMJ. 1995 Feb 18;310(6977):452-4. doi: 10.1136/bmj.310.6977.452.

(口服金制剂糖剂)对婴儿的免疫调节活性——一项随机对照临床试验

Immunomodulatory activity of (oral administration of gold as electuary) in infants - A randomized controlled clinical trial.

作者信息

Bhaskaran Jyothy Kothanath, Patel Kalpana Shantibhai, Srikrishna Rajagopala

机构信息

Department of Kaumarabhritya, Mahatma Gandhi Ayurved Medical College, Hospital and Research Centre, Constituent College of Datta Meghe Institute of Medical Sciences Deemed to be University, Wardha, Maharashtra, India.

Department of Kaumarabhritya, ITRA, Jamnagar, Gujarat, India.

出版信息

Ayu. 2019 Oct-Dec;40(4):230-236. doi: 10.4103/ayu.AYU_33_19. Epub 2021 Jan 14.

DOI:10.4103/ayu.AYU_33_19
PMID:33935440
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8078605/
Abstract

BACKGROUND

(oral administration of gold as electuary) is a form of electuary depicted in the classics of Ayurveda under the ambit of pediatrics. A specific action on immune system has been highlighted in infants if gold is administered along with and honey for a period of 28 days.

AIM

The present trial was conducted to assess the safety and efficacy of (calcined powder), (honey) and in infants with respect to anthropometrical, hematological and immunological parameters.

METHODOLOGY

The trial was a randomized, controlled, single-blind study in 102 healthy infants allocated into trial and control groups. Trial group received a mixture of , honey and , while control group received a mixture of honey and , both in drops form for a period of 4 weeks with 8 weeks follow-up. Safety was assessed on the basis of biochemical parameters and efficacy was based on the values of IgG before and after the treatment.

RESULTS

Anthropometrical and biochemical parameters did not showed any statistically significant difference between the effect of trial and control drugs, which suggested that the trial drugs did not hamper normal growth of the infants and were safe to be administered in infants. Both trial and control drugs showed statistically significant changes in IgG levels individually before and after the treatment; however, when compared between the groups, there was no significant differences. However, the number needed to treat (NNT) to assess the normalization of immunoglobulins, which is suggestive of its immunomodulatory activity, was 1 out of every 4.535 infants who received which was significant.

CONCLUSION

did not interfere with normal growth of the infants. As evident by NNT, it showed immunomodulatory activity and was tolerated by the infants with no adverse effects during the trial or follow-up period.

摘要

背景

(口服金剂作为糖膏剂)是阿育吠陀经典中描述的一种儿科范围内的糖膏剂形式。如果在28天内将金剂与[具体物质]和蜂蜜一起给婴儿服用,已强调其对免疫系统有特定作用。

目的

本试验旨在评估[煅烧粉末]、[蜂蜜]和[具体物质]在婴儿的人体测量学、血液学和免疫学参数方面的安全性和有效性。

方法

该试验是一项随机、对照、单盲研究,将102名健康婴儿分为试验组和对照组。试验组接受[煅烧粉末]、蜂蜜和[具体物质]的混合物,而对照组接受蜂蜜和[具体物质]的混合物,均为滴剂形式,为期4周,并进行8周的随访。根据生化参数评估安全性,有效性基于治疗前后IgG的值。

结果

试验药物和对照药物的效果在人体测量学和生化参数方面未显示出任何统计学上的显著差异,这表明试验药物不会妨碍婴儿的正常生长,并且对婴儿给药是安全的。试验药物和对照药物在治疗前后各自的IgG水平均显示出统计学上的显著变化;然而,在组间比较时,没有显著差异。但是,评估免疫球蛋白正常化所需的治疗人数(NNT)表明其具有免疫调节活性,每4.535名接受[煅烧粉末]的婴儿中有1名显著。

结论

[煅烧粉末]不干扰婴儿的正常生长。从NNT可以明显看出,它具有免疫调节活性,并且在试验或随访期间婴儿能够耐受,没有不良反应。